Κυριακή 18 Σεπτεμβρίου 2022

Unveiling HERV‐K113‐ENV as SARS‐CoV‐2 severity admissible biomarker by mining transcriptome data

alexandrossfakianakis shared this article with you from Inoreader

Abstract

Discovering the severity biomarker for SASR-CoV-2 can reduce the unnecessary hospital occupancy of COVID-19-positive adult people. Here we report the human endogenous retrovirus K113 envelope (HERV-K113-ENV) transcription as an admissible SARS-CoV-2 severity biomarker by the mining of adult Indian whole-blood transcriptome data.

This article is protected by copyright. All rights reserved.

View on Web

Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου

Αρχειοθήκη ιστολογίου